| Literature DB >> 24630762 |
Annie K McAuley1, Paul G Sanfilippo2, Alex W Hewitt2, Helena Liang3, Ecosse Lamoureux4, Jie Jin Wang5, Paul P Connell6.
Abstract
The aim of this study was to perform a systematic meta-analysis of biomarkers investigated with diabetic retinopathy (DR) in the vitreous, and to explore the molecular pathway interactions of these markers found to be consistently associated with DR. Relevant databases [PubMed and ISI web of science] were searched for all published articles investigating molecular biomarkers of the vitreous associated with DR. Based on set exclusion/inclusion criteria available data from studies with human vitreous samples were extracted and used for our meta-analysis. The interactions of significant biomarkers in DR were investigated via STRING and KEGG pathway analysis. Our meta-analysis of DR identifies eleven biomarkers as potential therapeutic candidates alternate to current anti-VEGF therapy. Four of these are deemed viable therapeutic targets for PDR; ET receptors (ET A and ET B), anti-PDGF-BB, blocking TGF-β using cell therapy and PEDF. The identification of supplementary or synergistic therapeutic candidates to anti VEGF in the treatment of DR may aid in the development of future treatment trials.Entities:
Keywords: EPO; HGF; IL-6; IL-8; KEGG pathway; Macular edema; Proliferative retinopathy; VEGF; Vitrectomy
Mesh：
Substances：
Year: 2013 PMID： 24630762 DOI： 10.1016/j.jdiacomp.2013.09.010
Source DB: PubMed Journal: J Diabetes Complications ISSN： 1056-8727 Impact factor: 2.852